INTERMITTENT ACCESS TO GLP-1 DRUGS STILL YIELDS WEIGHT LOSS Popular GLP-1 anti-obesity medications are effective for weight loss even when treatment is inconsistent, new findings suggest
Vitamin B12 belongs to the water-soluble B-complex group but exhibits unusual storage capacity, with the liver holding 25 mg for 35 years
this is often around 90 days from compounding when refrigerated, or shorter if stored at room temperature as stability permits
At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk
Most patients report significant improvement within 2 to 4 weeks
GLP-1 medications may not be appropriate for patients with certain medical histories, including specific thyroid cancer risks, multiple endocrine neoplasia syndrome type 2, serious allergic reactions to the medication or certain gastrointestinal or pancreatic concerns
